Peptide LocalCompare price, evidence & access
Search /Compare vendors
Regions/Global status checker
One name + one destination

Peptide status
by country.

Check whether a name resolves to a research listing, investigational program, or approved medicine, then open the exact product and seller records for the destination country.

Identity+Destination=Verification route
41tracked names
42country guides
3separate evidence lanes
99official source routes
Global source router

Two selections. No category shortcuts.

Start with a peptide name and destination. The result shows what the name means in our evidence database and which local records must be checked next.

Status check updated to SCENESSE in Việt Nam. Product-specific FDA and EU medicine records.

Current source route

SCENESSE in Việt Nam

Open exact country guide
Direct answer / Việt Nam

Can you buy SCENESSE in Việt Nam?

Product-specific FDA and EU medicine records

SCENESSE is a product-specific afamelanotide 16 mg implant authorized in the United States and European Union for narrowly defined erythropoietic protoporphyria uses. Those authorizations do not transfer to seller-labelled Melanotan I research vials, compounded products, other presentations, indications, online sellers, or supply routes, and they do not establish local availability in every country.

  1. 01
    Resolve the nameFDA-approved medicine
  2. 02
    Check Việt NamFDA-approved medicine
  3. 03
    Verify the exact offerProduct, seller, and supply route must match
Identity recordProduct-specific FDA and EU medicine records

What SCENESSE resolves to

SCENESSE is a product-specific afamelanotide 16 mg implant authorized in the United States and European Union for narrowly defined erythropoietic protoporphyria uses. Those authorizations do not transfer to seller-labelled Melanotan I research vials, compounded products, other presentations, indications, online sellers, or supply routes, and they do not establish local availability in every country.

Evidence lane
FDA-approved medicine
Current record
NDA 210797 · FDA-approved prescription drug
Checked
July 17, 2026
afamelanotideScenesseCUV1647NDA 210797alpha-MSH analog
Destination recordPhải đối chiếu sản phẩm và đường cung ứng trong hồ sơ DAV

What Việt Nam still has to prove

Hướng dẫn dành cho người tìm peptide, thuốc peptide, thuốc kiểm soát cân nặng hoặc vật liệu nghiên cứu tại Việt Nam. Bắt đầu bằng dữ liệu giấy đăng ký thuốc của Cục Quản lý Dược, sau đó kiểm tra thông tin cơ sở bán buôn hoặc đường cung ứng liên quan thay vì xem tên hoạt chất, trang tiếng Việt hay báo giá bằng đồng Việt Nam là bằng chứng đầy đủ.

Comparison mode
VND / hồ sơ đăng ký thuốc và cơ sở cung ứng của DAV
Price coverage
Chưa có bảng giá người bán Việt Nam đạt tiêu chuẩn xuất bản
Guide updated
18 tháng 7 năm 2026
Product recordCông bố giấy đăng ký thuốc và nguyên liệu làm thuốcCục Quản lý Dược, Bộ Y tế ↗Seller or supply recordThông tin cơ sở bán buôn thuốcCục Quản lý Dược, Bộ Y tế ↗
Evidence coverageRouting records only

No compound-specific official record is attached to this exact pairing yet. That is an evidence gap, not proof of approval, prohibition, availability, or absence. Use the country guide and official product and seller routes to verify the exact offer.

Open the full country check
Result boundaryIdentity match ≠ destination approval ≠ verified seller

This check routes each question to the right record. It is not a medical recommendation, legal opinion, local availability claim, or commercial ranking.

Popular starting points

Open a common peptide and country check.

Each selection has a shareable URL, so you can send someone the exact peptide and destination without losing the identity or country context.

01CagriSema in South AfricaInvestigational clinical program02CagriSema in PortugalInvestigational clinical program03Retatrutide in ArgentinaInvestigational clinical program04Melanotan II in ItaliaUS research-market identity05PT-141 / Bremelanotide in ItaliaUS research-market identity with a separate FDA-approved medicine record06CJC-1295 DAC in FranceUS research-market identity07BPC-157 in FranceUS research-market identity08BPC-157 in DeutschlandUS research-market identity09Retatrutide in MéxicoInvestigational clinical program10Mazdutide in 中国China-approved medicine and active clinical program11Ecnoglutide in 中国China-approved medicine and active development program12Enicepatide in FranceInvestigational clinical program13Eloralintide in DeutschlandInvestigational clinical program14Tirzepatide in CanadaUS FDA medicine reference15Cagrilintide in United KingdomInvestigational clinical program16Petrelintide in DeutschlandInvestigational clinical program17MariTide in AustraliaInvestigational clinical program18Survodutide in FranceInvestigational clinical program19VK2735 in United StatesInvestigational clinical program20Pemvidutide in United StatesInvestigational clinical program21Semaglutide in الإمارات العربية المتحدةProduct-specific approved medicine records in multiple jurisdictions22Semaglutide in FranceProduct-specific approved medicine records in multiple jurisdictions23Semaglutide in CanadaProduct-specific approved medicine records in multiple jurisdictions24TB-500 in United StatesUS research-market identity25TB-500 in CanadaUS research-market identity26GHK-Cu in CanadaUS research-market identity27Semax in South AfricaUS research-market identity28Melanotan II in AustraliaUS research-market identity29MOTS-c in CanadaUS research-market identity30Tesamorelin in United StatesUS research-market identity with a separate FDA-licensed medicine record31AOD-9604 in South AfricaUS research-market identity with a failed oral obesity program and no FDA-approved drug32Ipamorelin in CanadaUS research-market identity33Selank in South AfricaUS research-market identity34PT-141 / Bremelanotide in United StatesUS research-market identity with a separate FDA-approved medicine record35CJC-1295 no DAC in CanadaUS research-market identity36CJC-1295 DAC in South AfricaUS research-market identity
Direct answers

What a country check means.

The short answer is a routing decision, not a blanket legal, medical, or availability conclusion.

01

Is BPC-157 legal in every European country?

No region-wide answer is supportable from a seller page or a single database. Resolve the BPC-157 identity, choose the exact destination, then check that country’s product and seller or supply records.

02

Is retatrutide available as an approved medicine?

The Peptide Local identity record places retatrutide in the investigational clinical-program lane. A seller-labelled vial cannot inherit the sponsor’s trial material, evidence, or regulatory status.

03

Does a tirzepatide record prove local availability?

No. The FDA reference resolves the US medicine identity. Authorization, presentation, prescription status, current market presence, and seller authority must still be confirmed in the selected country.

Why the split matters

A matching name is only the first record.

  1. 01

    Resolve identity

    Keep the active ingredient, research label, clinical program, sponsor code, and approved brand attached to their proper source.

  2. 02

    Resolve destination

    Open the national product database and the separate pharmacy, establishment, professional, seller, or supply record linked for that country.

  3. 03

    Resolve the exact offer

    Match the legal seller identity, product presentation, claimed category, current status, and delivery route. Do not transfer evidence between unlike products.

Continue the evidence trail
Search the complete peptide database ↗Compare all five world regions ↗Open all country, province, state, region, and city guides ↗